Sells prescription eyewear and smart glasses through company-owned retail stores in India and abroad, and uses in-store eye tests as the main entry point for dispensing glasses. India accounted for 59.3% of FY26 segment revenue at ₹5,260.081 cr and International for 40.7% at ₹3,606.022 cr. India delivered Q4 FY26 revenue of ₹1,475 cr (+44% YoY) at 15.3% EBITDA margin, while International delivered ₹1,054 cr (+35% YoY) at 9.2% margin. Added 542 net new stores in FY26, with 718 located in International markets; conducted 6.8 million eye tests in Q4 FY26, of which roughly half were first-time exams. Recently launched B by Lenskart prescription smart glasses with a 30,000+ waitlist, and is setting up an India joint venture with China's Mingfeng Glassesworld to manufacture metal spectacle frames domestically. The largest identified input cost is materials (lenses and frames) at 25.6% of revenue, followed by employee costs at 23.2% and depreciation at 11.9%. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. India (59%), International (41%). Asset-heavy specialty retail with vertical manufacturing integration, omnichannel stores and international expansion
| ₹ crore · consolidated | FY26 |
|---|---|
| Revenue | 8,814 |
| EBITDA (ex other income) | 1,737 |
| margin % | 19.7 |
| Owners' profit | 494 |
| EPS, as reported (₹) | 2.91 |
| ROE % · ROCE % | 5.7 · 7.3 |
| Debt / equity (x) | 0.02 |
| Cash from operations | 1,670 |
| Capex | (828) |
| ₹ crore | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|
| Revenue | 2,096 | 2,308 | 2,516 | 2,714 |
| Profit before tax | 149 | 180 | 256 | 299 |
| Net profit | 103 | 133 | 204 | 228 |
| EPS (₹) | 0.61 | 0.77 | 1.17 | 1.28 |
| Segment | Revenue, ₹ crore | Share % |
|---|---|---|
| India | 4,091 | 58.9 |
| International | 2,870 | 41.3 |
| Total, before eliminations | 6,960 | 100.0 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| TRENT LTD | 1,49,424 | 60.9 | 21.02 | 39.8 | 24.2 | 26.2 | 50.6 | 20.1 |
| LENSKART SOLUTIONS LTD ◆ | 1,18,565 | 178.0 | 13.39 | 61.6 | 5.7 | 5.8 | — | 24.2 |
| VEDANT FASHIONS LIMITED | 14,190 | 35.2 | 9.29 | 19.5 | 8.5 | 8.4 | — | 52.7 |
| ADITYA BIRLA LIFES BRAN L | 10,194 | 57.6 | 7.22 | 7.9 | 12.1 | 5.0 | — |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 27 Aug 2026 · Foreign investor SVF II Lightbulb sells 2.59% stake in Lenskart via open market | ownership changes | high | — | — |
| 20 Aug 2026 · Cyber incident at sub-vendor of Singapore group company, no disruption | business updates | medium | — | — |
| 20 Aug 2026 · Lenskart 18th AGM voting results - all 4 resolutions passed | board shareholder meetings | medium | — | — |
| 19 Aug 2026 · Lenskart Q1 FY27 earnings call: revenue up 34%, PAT jumps 182% to Rs 228 cr | investor communications | medium | — | — |
| 19 Aug 2026 · Lenskart holds 18th AGM on Aug 19, 2026; voting results awaited in 2 working days | board shareholder meetings | medium | — | — |
| 17 Aug 2026 · Lenskart sets up step-down subsidiary in China for eyewear frame trading | strategic transactions | medium | — | — |
| 13 Aug 2026 · Lenskart IPO funds: Rs 186.71 cr used in Q1 FY27, no deviations | fund raising | medium | — | — |
| 13 Aug 2026 · Audio recording of Q1 FY27 earnings call now available | investor communications | low | — | — |
| 13 Aug 2026 · Lenskart files Q1 FY27 results newspaper clippings with exchanges | compliance | minimal | — | — |
| 13 Aug 2026 · Newspaper publication of Q1 FY27 financial results | compliance | minimal | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) |
| 16.0 |
| ADITYA VISION LIMITED | 7,991 | 57.4 | 11.61 | — | 17.0 | 17.4 | — | 10.6 |
| V2 RETAIL LIMITED | 7,947 | 5.1 | 8.81 | 16.6 | 18.0 | 14.2 | 41.6 | 14.1 |
| ADITYA BIRLA FASHION & RT | 6,164 | — | 0.98 | 8.4 | (13.3) | (7.1) | 9.3 | 8.5 |
| ARVIND FASHIONS LIMITED | 5,946 | 49.5 | 5.12 | 8.9 | 15.8 | 12.9 | 19.1 | 13.0 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 178.0 | 21.9 | 18 of 19 | 6% |
| P/B | 13.4 | 4.3 | 13 of 14 | 8% |
| ROCE | 5.8 | 10.0 | 14 of 20 | 32% |
| ROE | 5.7 | 11.7 | 11 of 14 | 23% |
| Debt / Equity | 0.0 | 0.1 | 5 of 14 | 69% |
| EBITDA margin | 24.2 | 15.7 | 5 of 14 | 69% |
| Market cap | 118565 | 845 | 2 of 20 | 95% |
| A state: the latest filed quarter and the measured reactions |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
